Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Malic acid to lactic acid metabolic pathway describes the cellular process in certain bacteria and fungi where L-malic acid is converted into L-lactic acid and CO₂. This transformation is catalyzed mainly by the malolactic enzyme (MLE), and sometimes by malic enzyme (ME) via pyruvate. In lactic acid bacteria such as Lactobacillus casei, malolactic fermentation is important for reducing the acidity of products like wine and for microbial stability. Regulation of these pathways involves specific gene clusters and transporters required for malate uptake (MleT, MaeP) and is coupled with transcriptional regulation (MleR, MaeR). The process is energetically favorable for deacidification but less suited for cell growth on malic acid as a sole carbon source. In winemaking, controlling this pathway is crucial for final product properties and stability[1][2][3].
Enzyme inhibition for malolactic enzyme (competitive and non-competitive inhibitors as described above[2])
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Malic acid to lactic acid metabolic pathway.